Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C10AA02 LOVASTATINUM COMPR. 20 mg

MEDOSTATIN 20 mg MEDOCHEMIE LTD.

________________________________________________________________________________

______________________________________________________________________________

| 64 |C10AA03| PRAVASTATINUM | Protocol: CE01E |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Se utilizează pentru pacienţii care îndeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C10AA03 PRAVASTATINUM COMPR. 10 mg

PRALIP 10 mg 10 mg SANDOZ SRL

PRAVATOR 10 mg 10 mg RANBAXY U.K. LIMITED

C10AA03 PRAVASTATINUM COMPR. 20 mg

PRALIP 20 mg 20 mg SANDOZ SRL

PRAVATOR 20 mg 20 mg RANBAXY U.K. LIMITED
C10AA03 PRAVASTATINUM COMPR. 40 mg

PRALIP 40 mg 40 mg SANDOZ SRL

PRAVATOR 40 mg 40 mg RANBAXY U.K. LIMITED

________________________________________________________________________________

______________________________________________________________________________

| 65 |C10AB05| FENOFIBRATUM | Protocol: CE01E |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Se utilizează pentru pacienţii care îndeplinesc criteriile de eligibilitate stabilite prin Protocolul de prescriere a medicamentelor hipolipemiante.
NOTĂ:

Riscul de toxicitate musculară severă creşte dacă fenofibratum este utilizat simultan cu inhibitori de HMG CoA reductaza sau alţi fibraţi. Terapia combinată trebuie folosită cu precauţie la pacienţii cu dislipidemie mixtă severă combinată cu risc cardiovascular înalt, în absenţa antecedentelor de afecţiune musculară. Pacienţii vor fi monitorizaţi regulat pentru semne cronice de toxicitate musculară.
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C10AB05 FENOFIBRATUM CAPS. 100 mg

LIPANTHYL(R) 100 100 mg LAB. FOURNIER SA
C10AB05 FENOFIBRATUM CAPS. 160 mg

LIPOFIB 160 mg 160 mg TERAPIA S.A.

C10AB05 FENOFIBRATUM COMPR. FILM. ELIB. 160 mg

MODIF.

LIPANTHYL(R) SUPRA 160 mg 160 mg LAB. FOURNIER SA
C10AB05 FENOFIBRATUM CAPS. 200 mg

LIPOFIB 200 mg 200 mg TERAPIA S.A.

C10AB05 FENOFIBRATUM CAPS. PULB. MICRONIZATĂ 200 mg

FENOFIBRAT LPH 200 mg 200 mg LABORMED PHARMA SA

LIPANTHYL 200 M 200 mg LAB. FOURNIER SA

LIPIVIM 200 mg VIM SPECTRUM SRL

________________________________________________________________________________
______________________________________________________________________________

| 66 |D01AC02| MICONAZOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D01AC02 MICONAZOLUM CREMĂ 20 mg/g

MICONAL ECOBI 20 mg/g FARMACEUTICI ECOBI S.A.S.
D01AC02 MICONAZOLUM CREMĂ 2%

MEDACTER 2% FARAN LABORATORIES S.A.

MICONAZOL NITRAT 2% 2% SLAVIA PHARM SRL
D01AC02 MICONAZOLUM GEL 2%

DERMOZOL 2% PHARCOIMPEX 93 S.R.L.

________________________________________________________________________________
______________________________________________________________________________

| 67 |D01AC10| BIFONAZOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D01AC10 BIFONAZOLUM SOL. CUT. 0,01 g/ml

MYCOSPOR 0,01 g/ml BAYER HEALTHCARE AG
D01AC10 BIFONAZOLUM CREMĂ 100 g

MYCO-FLUSEMIDON 100 g ANFARM HELLAS S.A.

PHARMACEUTICALS
D01AC10 BIFONAZOLUM CREMĂ 10 mg/g

BIAZOL 10 mg/g 10 mg/g GEDEON RICHTER ROMANIA SA

D01AC10 BIFONAZOLUM CREMĂ 1%

MYCOSPOR 1% BAYER HEALTHCARE AG

________________________________________________________________________________
______________________________________________________________________________

| 68 |D06BB03| ACICLOVIRUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D06BB03 ACICLOVIRUM CREMĂ 50 mg/g

ACICLOVIR HYPERION 50 mg/g HYPERION S.A.

ACIKLOVIR CREMĂ 50 mg/g A & G MED TRADING S.R.L.

D06BB03 ACICLOVIRUM CREMĂ 5%

ACICLOVIR 5% OZONE LABORATORIES LTD.

ACICLOVIR 5% 5% GEDEON RICHTER ROMANIA SA

CLOVIRAL(R) 5% 5% ANTIBIOTICE SA

ZOVIRAX 5% THE WELLCOME FOUNDATION

LTD.

________________________________________________________________________________
______________________________________________________________________________

| 69 |D07AA02| HYDROCORTISONUM | Protocol: D001L |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07AA02 HYDROCORTISONUM UNGUENT 1,00%

HIDROCORTIZON 1% 1% ANTIBIOTICE SA

________________________________________________________________________________

______________________________________________________________________________

| 70 |D07AC01| BETAMETHASONUM | Protocol: D001L |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

D07AC01 BETAMETHASONUM CREMĂ 0,5 mg/g

BELODERM CREMĂ 0,5 mg/g A & G MED TRADING S.R.L.
D07AC01 BETAMETHASONUM UNGUENT 0,5 mg/g

BELODERM UNGUENT 0,5 mg/g A & G MED TRADING S.R.L.

D07AC01 BETAMETHASONUM CREMĂ 0.1%

BETADERM 0.1% E.I.P.I.CO. MED S.R.L.

D07AC01 BETAMETHASONUM UNGUENT 0.1%

BETADERM 0.1% E.I.P.I.CO. MED S.R.L.

________________________________________________________________________________
______________________________________________________________________________

| 71 |G01AF04| MICONAZOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G01AF04 MICONAZOLUM CAPS. MOI VAG. 1.2 g

MICONAL ECOBI 1.2 g FARMACEUTICI ECOBI S.A.S
G01AF04 MICONAZOLUM CREMĂ VAG. 20 mg/g

MICONALECOBI 20 mg/g FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM SOL. VAGINALĂ 2 mg/ml

MICONAL ECOBI 2 mg/ml FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM OVULE 50 mg

MICONALECOBI 50 mg FARMACEUTICI ECOBI S.A.S

G01AF04 MICONAZOLUM CREMĂ VAG. 2%

MEDACTER 2% FARAN LABORATORIES S.A.

MYCOHEAL 2% DAR AL DAWA PHARMA S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 72 |G02AB03| ERGOMETRINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G02AB03 ERGOMETRINUM SOL. INJ. 0.2 mg/ml

MALEAT DE ERGOMETRINA 0.2 mg/ml ZENTIVA S.A.

0,2 mg/ml

________________________________________________________________________________
______________________________________________________________________________

| 73 |G03BA03| TESTOSTERONUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G03BA03 TESTOSTERONUM SOL. INJ. 1000 mg/4 ml

NEBIDO 1000 mg/4 ml 1000 mg/4 ml SCHERING AG
G03BA03 TESTOSTERONUM CAPS. MOI 40 mg

UNDESTO(R) TESTOCAPS(R) 40 mg ORGANON NV

Prescriere limitată: Deficit androgenic la bărbaţi de cauză primară testiculară sau secundară hipotalamo-hipofizară (confirmat prin nivel plasmatic al testosteronului la cel puţin 2 determinări în două dimineţi diferite mai mic sau egal cu limita inferioară a valorilor reactivului utilizat).

Prescriere limitată: Micropenis, inducerea pubertăţii sau întârzierea constituţională a creşterii sau a pubertăţii la băieţi sub 18 ani.

G03BA03 TESTOSTERONUM GEL 50 mg

ANDROGEL 50 mg 50 mg LAB. BESINS INTERNATIONAL

________________________________________________________________________________
______________________________________________________________________________

| 74 |G03CA03| ESTRADIOLUM* | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Utilizat în simptomele caracteristice post-menopauzei, în cazul în care terapia estrogenică în doze reduse a demonstrat intoleranţa la administrarea orală cu estrogeni.

Această limitare este valabilă doar pentru formele farmaceutice Sistem terapeutic transdermic şi plasture transdermic.
NOTĂ:

Estradiol trebuie folosit împreună cu un progestativ oral la femeile nehisterectomizate.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G03CA03 ESTRADIOLUM GEL 0.06%

OESTROGEL(R) 0.06% LAB. BESINS INTERNATIONAL
G03CA03 ESTRADIOLUM GEL 0.1%

ESTREVA(R) 0.1% LAB. THERAMEX

G03CA03 ESTRADIOLUM COMPR. FILM. 1 mg

ESTROFEM 1 mg 1 mg NOVO NORDISK A/S

G03CA03 ESTRADIOLUM COMPR. VAG. 25 µg

VAGIFEM 25 µg NOVO NORDISK A/S

G03CA03 ESTRADIOLUM IMPLANT 25 mg

RISELLE 25 mg 25 mg ORGANON NV

G03CA03 ESTRADIOLUM PLASTURE TRANSDERM. 50 µg/24 ore

CLIMARA 50 µg/24 ore SCHERING AG

________________________________________________________________________________
______________________________________________________________________________

| 75 |G04CAN1| DOXAZOSINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

G04CAN1 DOXAZOSINUM COMPR. 1 mg

DOXAZOSIN 1 MEDOCHEMIE 1 mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 1 1 mg ALIUD(R) PHARMA GMBH &

CO.KG

KAMIREN 1 mg KRKA D.D. NOVO MESTO

MAGUROL 1 mg MEDOCHEMIE LTD.
G04CAN1 DOXAZOSINUM COMPR. 2 mg

DOXAZOSIN 2 MEDOCHEMIE 2 mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 2 2 mg ALIUD(R) PHARMA GMBH &

CO.KG

DOXAZOSIN SANDOZ 2 mg 2 mg HEXAL AG

KAMIREN 2 mg KRKA D.D. NOVO MESTO

MAGUROL 2 mg MEDOCHEMIE LTD.
G04CAN1 DOXAZOSINUM COMPR. 4 mg

DOXAZOSIN 4 MEDOCHEMIE 4 mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 4 4 mg ALIUD(R) PHARMA GMBH &

CO.KG

KAMIREN 4 mg KRKA D.D. NOVO MESTO

MAGUROL 4 mg MEDOCHEMIE LTD.

G04CAN1 DOXAZOSINUM COMPR. ELIB. MODIF. 4 mg

CARDURA XL 4 mg 4 mg PFIZER H.C.P. CORPORATION

G04CAN1 DOXAZOSINUM COMPR. FILM. ELIB. 4 mg

PREL.

KAMIREN XL 4 mg 4 mg KRKA D.D. NOVO MESTO
G04CAN1 DOXAZOSINUM COMPR. 1 mg

DOXAZOSIN 1 MEDOCHEMIE 1 mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 1 1 mg ALIUD(R) PHARMA GMBH &

CO.KG

KAMIREN 1 mg KRKA D.D. NOVO MESTO

MAGUROL 1 mg MEDOCHEMIE LTD.

G04CAN1 DOXAZOSINUM COMPR. 2 mg

DOXAZOSIN 2 MEDOCHEMIE 2 mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 2 2 mg ALIUD(R) PHARMA GMBH &

CO.KG

DOXAZOSIN SANDOZ 2 mg 2 mg HEXAL AG

KAMIREN 2 mg KRKA D.D. NOVO MESTO

MAGUROL 2 mg MEDOCHEMIE LTD.
G04CAN1 DOXAZOSINUM COMPR. 4 mg

DOXAZOSIN 4 MEDOCHEMIE 4 mg MEDOCHEMIE ROMANIA SRL

DOXAZOSIN AL 4 4 mg ALIUD(R) PHARMA GMBH &

CO.KG

DOXAZOSIN SANDOZ 4 mg 4 mg HEXAL AG

KAMIREN 4 mg KRKA D.D. NOVO MESTO

MAGUROL 4 mg MEDOCHEMIE LTD.
G04CAN1 DOXAZOSINUM COMPR. ELIB. MODIF. 4 mg

CARDURA XL 4 mg 4 mg PFIZER H.C.P. CORPORATION

G04CAN1 DOXAZOSINUM COMPR. FILM. ELIB. 4 mg

PREL.

KAMIREN XL 4 mg 4 mg KRKA D.D. NOVO MESTO

________________________________________________________________________________

______________________________________________________________________________

| 76 |H02AB04| METHYLPREDNISOLONUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 125 mg

LEMOD SOLU 125 mg 125 mg HEMOFARM S.R.L.
H02AB04 METHYLPREDNISOLONUM LIOF. ŞI SOLV. PT. SOL. 125 mg/2 ml

INJ.

SOLU-MEDROL ACT-O-VIAL 125 mg/2 ml PFIZER EUROPE MA EEIG
H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 20 mg

LEMOD SOLU 20 mg 20 mg HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM LIOF. ŞI SOLV. PT. SOL. 250 mg/4 ml

INJ.

SOLU-MEDROL ACT-O-VIAL 250 mg/4 ml PFIZER EUROPE MA EEIG
H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 40 mg

LEMOD SOLU 40 mg 40 mg HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM LIOF. ŞI SOLV. PT. SOL. 40 mg/1 ml

INJ.

SOLU-MEDROL ACT-O-VIAL 40 mg/1 ml PFIZER EUROPE MA EEIG
H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 500 mg

LEMOD SOLU 500 mg 500 mg HEMOFARM S.R.L.

H02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. 500 mg/7.8 ml

INJ.

SOLU-MEDROL 500 mg/7,8 ml 500 mg/7.8 ml PFIZER EUROPE MA EEIG

________________________________________________________________________________

______________________________________________________________________________

| 77 |H02AB07| PREDNISONUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

H02AB07 PREDNISONUM COMPR. 5 mg

N-PREDNISON 5 mg MEDUMAN SA

PREDNISON 5 mg 5 mg SINTOFARM SA

PREDNISON ARENA 5 mg 5 mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5 mg GEDEON RICHTER ROMÂNIA SA

PREDNISON MAGISTRA 5 mg 5 mg MAGISTRA C & C

________________________________________________________________________________

______________________________________________________________________________

| 78 |H02AB09| HYDROCORTISONUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

H02AB09 HYDROCORTISONUM LIOF. + SOLV. PT. SOL. 100 mg

INJ.

HYDROCORTISONE 100 mg 100 mg HEMOFARM S.R.L.

HYDROCORTISONE SUCCINAT SODIC 100 mg E.I.P.I.CO. MED S.R.L.
H02AB09 HYDROCORTISONUM SOL. INJ. I.V. 25 mg/5 ml

HIDROCORTIZON HEMISUCCINAT 25 mg/5 ml ZENTIVA S.A.

H02AB09 HYDROCORTISONUM LIOF. PT. SOL. INJ. + 500 mg

SOLV.

HYDROCORTISONE 500 mg 500 mg HEMOFARM S.R.L.

________________________________________________________________________________

______________________________________________________________________________

| 79 |J01AA02| DOXYCYCLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01AA02 DOXYCYCLINUM CAPS. 100 mg

DOXICICLINA 100 mg EUROPHARM SA

DOXICICLINA 100 mg 100 mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100 mg SANDOZ SRL
J01AA02 DOXYCYCLINUM COMPR. DISP. 100 mg

UNIDOX SOLUTAB 100 mg ASTELLAS PHARMA EUROPE

B.V.
J01AA02 DOXYCYCLINUM CAPS. 100 mg

DOXICICLINA 100 mg ARENA GROUP SA

DOXICICLINA 100 mg 100 mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100 mg SANDOZ SRL

J01AA02 DOXYCYCLINUM COMPR. DISP. 100 mg

UNIDOX SOLUTAB 100 mg ASTELLAS PHARMA EUROPE

B.V.
J01AA02 DOXYCYCLINUM CAPS. 100 mg

DOXICICLINA 100 mg ARENA GROUP SA

DOXICICLINA 100 mg 100 mg ANTIBIOTICE SA

DOXICICLINA SANDOZ 100 mg 100 mg SANDOZ SRL

J01AA02 DOXYCYCLINUM COMPR. DISP. 100 mg

UNIDOX SOLUTAB 100 mg ASTELLAS PHARMA EUROPE

B.V.

________________________________________________________________________________

______________________________________________________________________________

| 80 |J01CA04| AMOXICILLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CA04 AMOXICILLINUM COMPR. FILM. 1000 mg

OSPAMOX 1000 mg 1000 mg SANDOZ GMBH
J01CA04 AMOXICILLINUM PULB. PT. SUSP. ORALĂ 125 mg/5 ml

AMOXICILINA 125 mg/5 ml 125 mg/5 ml OZONE LABORATORIES LTD.

AMOXICILINA SANDOZ 125 mg/5 ml SANDOZ S.R.L.

125 mg/5 ml PULBERE PENTRU

SUSPENSIE ORALĂ

JULPHAMOX 125 mg/5 ml GULF PHARMACEUTICAL

INDUSTRIES S.R.L.

OSPAMOX(R) 125 mg/5 ml 125 mg/5 ml SANDOZ GMBH

J01CA04 AMOXICILLINUM PULB. SUSP. 125 mg/5 ml

MOXILEN 125 mg/5 ml MEDOCHEMIE LTD.

J01CA04 AMOXICILLINUM CAPS. 250 mg

AMOXICILINA 250 mg EUROPHARM SA

AMOXICILINA SANDOZ 250 mg 250 mg SANDOZ SRL

CAPSULE

AMOXICILINA 250 mg 250 mg OZONE LABORATORIES LTD.

AMOXICILINA ANTIBIOTICE 250 mg ANTIBIOTICE SA

250 mg

AMOXICILINA ARENA 250 mg 250 mg ARENA GROUP SA

AMOXICILINA MEDICO UNO 250 mg 250 mg MEDICO UNO PHARMACEUTICAL

S.R.L.

OSPAMOX 250 mg 250 mg SANDOZ GMBH
J01CA04 AMOXICILLINUM PULB. PT. SUSP. ORALĂ 250 mg/5 ml

AMOXICILINA SANDOZ 250 mg/5 ml SANDOZ S.R.L.

250 mg/5 ml PULBERE PENTRU

SUSPENSIE ORALĂ

AMOXICILINA 250 mg/5 ml 250 mg/5 ml OZONE LABORATORIES LTD.

E-MOX 250 mg/5 ml E.I.P.I.CO. MED S.R.L.

JULPHAMOX 250 mg/5 ml GULF PHARMACEUTICAL

INDUSTRIES S.R.L.

OSPAMOX 250 mg/5 ml 250 mg/5 ml SANDOZ GMBH
J01CA04 AMOXICILLINUM PULB. SUSP. 250 mg/5 ml

MOXILEN FORTE 250 mg/5 ml MEDOCHEMIE LTD.

J01CA04 AMOXICILLINUM CAPS. 500 mg

AMOXICILINA ANTIBIOTICE 500 mg ANTIBIOTICE SA

500 mg

AMOXICILINA ARENA 500 mg 500 mg ARENA GROUP SA

AMOXICILINA FORTE 500 mg 500 mg OZONE LABORATORIES LTD.

AMOXICILINA SANDOZ 500 mg 500 mg SANDOZ SRL

CAPSULE

E-MOX 500 mg E.I.P.I.CO. MED S.R.L.

EPHAMOX 500 mg EUROPHARM SA

MOXILEN 500 mg MEDOCHEMIE LTD.

J01CA04 AMOXICILLINUM COMPR. FILM. 500 mg

OSPAMOX 500 mg 500 mg SANDOZ GMBH

J01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE 1000 mg

ORALĂ

DUOMOX 1000 mg 1000 mg ASTELLAS PHARMA EUROPE BV
J01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE 250 mg

ORALĂ

DUOMOX 250 mg 250 mg ASTELLAS PHARMA EUROPE BV
J01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE 500 mg

ORALĂ

DUOMOX 500 mg 500 mg ASTELLAS PHARMA EUROPE BV
J01CA04 AMOXICILLINUM COMPR. PT. DISPERSIE 750 mg

ORALĂ

DUOMOX 750 mg 750 mg ASTELLAS PHARMA EUROPE BV

________________________________________________________________________________

______________________________________________________________________________

| 81 |J01CE02| PHENOXYMETHYLPENICILLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CE02 PHENOXY- COMPR. 1000000 ui

METHYLPENICILLINUM

PENICILINA V 1 000 000 U.I. 1000000 ui EUROPHARM SA

J01CE02 PHENOXY- COMPR. FILM. 1000000 ui

METHYLPENICILLINUM

OSPEN(R) 1000 1000000 ui SANDOZ GMBH
J01CE02 PHENOXY- COMPR. FILM. 1500000 ui

METHYLPENICILLINUM

OSPEN(R) 1500 1500000 ui SANDOZ GMBH
J01CE02 PHENOXY- SIROP 400000 ui/5 ml

METHYLPENICILLINUM

OSPEN 400 400000 ui/5 ml SANDOZ GMBH
J01CE02 PHENOXY- COMPR. FILM. 500000 ui

METHYLPENICILLINUM

OSPEN(R) 500 500000 ui SANDOZ GMBH

________________________________________________________________________________

______________________________________________________________________________

| 82 |J01CE08| BENZATHINI BENZYLPENICILLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CE08 BENZATHINI PULB. PT. SUSP. INJ. 1200000 ui

BENZYLPENICILLINUM

MOLDAMIN(R) 1200000 ui ANTIBIOTICE SA

J01CE08 BENZATHINI PULB. PT. SUSP. INJ. 600000 ui

BENZYLPENICILLINUM

MOLDAMIN(R) 600000 ui ANTIBIOTICE SA

________________________________________________________________________________

______________________________________________________________________________

| 83 |J01CF04| OXACILLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01CF04 OXACILLINUM CAPS. 250 mg

OXACILINA 250 mg FARMACOM SA

OXACILINA 250 mg 250 mg ANTIBIOTICE SA

OXACILINA ARENA 250 mg 250 mg ARENA GROUP SA

OXACILINA FARMEX 250 mg 250 mg FARMEX COMPANY SRL

OXACILINA SANDOZ 250 mg 250 mg SANDOZ SRL
J01CF04 OXACILLINUM CAPS. 500 mg

OXACILINA 500 mg 500 mg ANTIBIOTICE SA

OXACILINA ARENA 500 mg 500 mg ARENA GROUP SA

OXACILINA FORTE 500 mg 500 mg OZONE LABORATORIES LTD.

OXACILINA SANDOZ 500 mg 500 mg SANDOZ SRL

OXALIN 500 mg 500 mg EUROPHARM SA

J01CF04 OXACILLINUM PULB. PT. SOL. INJ./ 1 g

PERF. I.M./I.V.

OXACILINA ANTIBIOTICE 1 g 1 g ANTIBIOTICE SA

________________________________________________________________________________

______________________________________________________________________________

| 84 |J01CR02| AMOXICILLINUM + ACIDUM CLAVULANICUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul de scurtă durată a infecţiilor bacteriene